This important investment in stem cell research is strengthening the state's position as a leader in biomedical research and biotechnology, while supporting the development of possible new therapies to alleviate and treat debilitating diseases and conditions, such as Alzheimer's, Parkinson's ALS, paralysis, and diabetes, said Commissioner Daines, who chairs the Empire State Stem Cell Board.